Skip to main content

Pulmozyme Prices, Coupons and Patient Assistance Programs

Pulmozyme (dornase alfa) is a member of the miscellaneous respiratory agents drug class and is commonly used for Cystic Fibrosis.

Pulmozyme Prices

The cost for Pulmozyme inhalation solution (2.5 mg/2.5 mL) is around $3,821 for a supply of 75 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

This Pulmozyme price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Inhalation Solution

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Pulmozyme Coupons and Rebates

Pulmozyme offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Pulmozyme Co-Pay Card Program: Eligible commercially insured patients pay as little as $30 per 30-day supply with savings of up to $10,000 per year; for additional information contact the program at 877-794-8723.

Applies to:
Pulmozyme
Number of uses:
per prescription per year

Form more information phone: 877-794-8723 or Visit website

Pulmozyme Co-Pay Card Reimbursement Request: Eligible commercially insured patients may submit a reimbursement request form after paying the provider directly for treatment; instructions for using the program are included on the form; for additional information contact the program at 877-794-8723.

Applies to:
Pulmozyme
Number of uses:
One rebate per prescription fill

Form more information phone: 877-794-8723 or Visit website

Patient Assistance Programs for Pulmozyme

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: HealthWell Foundation Copay Program

Elligibility requirements:
  1. May have insurance
  2. Varies
  3. FDA Approved Diagnosis - See Program Website for Details
  4. The patient must also be residing in the US.
  5. This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
Applicable drugs:
  • Pulmozyme (dornase alfa) Solution; Inhalation

More information please phone: 800-675-8416 Visit Website

Provider: Genentech Patient Foundation

Elligibility requirements:
  1. Uninsured or Underinsured with no prescription coverage for needed medication
  2. Income Guidelines published on Program Website
  3. Medically appropriate condition/diagnosis
  4. Must be treated by US licensed healthcare provider
  5. The Genentech Access to Care Foundation is now the Genentech Patient Foundation. Eligibility determined on a case-by-case basis. Call for most recent medications as the list is subject to change.
Applicable drugs:
  • Pulmozyme (dornase alfa) Solution; Inhalation

More information please phone: 888-941-3331 Visit Website

Provider: Genentech Access Solutions (Pulmozyme)

Elligibility requirements:
  1. Determined case by case
  2. Based on FPL
  3. Varies
  4. Must be treated by US licensed healthcare provider
  5. Eligibility determined on a case-by-case basis. Contact program for details.
Applicable drugs:
  • Pulmozyme (dornase alfa) Solution; Inhalation

More information please phone: 800-690-3023   or 866-422-2377   Visit Website